Methods to treat conditions mediated by chemokine receptors
US7160872B2 · kind B2 · utility
19Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2004 |
| Grant date | Jan 9, 2007 |
| Priority date | — |
| Expiry date | Jun 21, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is drawn to novel antiviral compounds, pharmaceutical compositions and their use. More specifically this invention is drawn to derivatives of monocyclic polyamines which have activity in standard tests against HIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors that mediate a number of mammalian embryonic developmental processes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.